205 related articles for article (PubMed ID: 31341433)
1. Treatment with EPs 7630, a
Riley DS; Lizogub VG; Heger M; Funk P; Mueller H; Lehmacher W
Integr Med (Encinitas); 2019 Feb; 18(1):42-51. PubMed ID: 31341433
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.
Lizogub VG; Riley DS; Heger M
Explore (NY); 2007; 3(6):573-84. PubMed ID: 18005909
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Tolerability of High-dose Pelargonium Extract in Patients With the Common Cold.
Riley DS; Lizogub VG; Zimmermann A; Funk P; Lehmacher W
Altern Ther Health Med; 2018 Mar; 24(2):16-26. PubMed ID: 29055287
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of extract of Pelargonium sidoides in children with acute non-group A beta-hemolytic streptococcus tonsillopharyngitis: a randomized, double-blind, placebo-controlled trial.
Bereznoy VV; Riley DS; Wassmer G; Heger M
Altern Ther Health Med; 2003; 9(5):68-79. PubMed ID: 14526713
[TBL] [Abstract][Full Text] [Related]
5. Treatment of acute bronchitis in adults with a pelargonium sidoides preparation (EPs 7630): a randomized, double-blind, placebo-controlled trial.
Chuchalin AG; Berman B; Lehmacher W
Explore (NY); 2005 Nov; 1(6):437-45. PubMed ID: 16781588
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of EPs 7630 in children and adolescents with acute bronchitis - a randomized, double-blind, placebo-controlled multicenter trial with a herbal drug preparation from Pelargonium sidoides roots.
Kamin W; Maydannik V; Malek FA; Kieser M
Int J Clin Pharmacol Ther; 2010 Mar; 48(3):184-91. PubMed ID: 20197012
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of an extract of Pelargonium sidoides (EPs 7630) in adults with acute bronchitis. A randomised, double-blind, placebo-controlled trial.
Matthys H; Eisebitt R; Seith B; Heger M
Phytomedicine; 2003; 10 Suppl 4():7-17. PubMed ID: 12807337
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of EPs 7630 tablets in patients with acute bronchitis: a randomised, double-blind, placebo-controlled dose-finding study with a herbal drug preparation from Pelargonium sidoides.
Matthys H; Lizogub VG; Malek FA; Kieser M
Curr Med Res Opin; 2010 Jun; 26(6):1413-22. PubMed ID: 20387996
[TBL] [Abstract][Full Text] [Related]
9. Pelargonium sidoides root extract for the treatment of acute cough due to lower respiratory tract infection in adults: a feasibility double-blind, placebo-controlled randomised trial.
Willcox M; Simpson C; Wilding S; Stuart B; Soilemezi D; Whitehead A; Morgan A; Wrixon E; Zhu S; Yao G; Webley F; Yan R; Bostock J; Bell M; Griffiths G; Leydon G; Little P; Butler C; Hay AD; Moore M
BMC Complement Med Ther; 2021 Jan; 21(1):48. PubMed ID: 33514367
[TBL] [Abstract][Full Text] [Related]
10. Pelargonium sidoides extract for treating acute respiratory tract infections.
Timmer A; Günther J; Motschall E; Rücker G; Antes G; Kern WV
Cochrane Database Syst Rev; 2013 Oct; (10):CD006323. PubMed ID: 24146345
[TBL] [Abstract][Full Text] [Related]
11. Treatment of acute rhinosinusitis with the preparation from Pelargonium sidoides EPs 7630: a randomized, double-blind, placebo-controlled trial.
Bachert C; Schapowal A; Funk P; Kieser M
Rhinology; 2009 Mar; 47(1):51-8. PubMed ID: 19382496
[TBL] [Abstract][Full Text] [Related]
12. Effects of Pelargonium sidoides extract EPs 7630 on acute cough and quality of life - a meta-analysis of randomized, placebo-controlled trials.
Kardos P; Lehmacher W; Zimmermann A; Brandes-Schramm J; Funk P; Matthys H; Kamin W
Multidiscip Respir Med; 2022 Jan; 17():868. PubMed ID: 36051888
[TBL] [Abstract][Full Text] [Related]
13. Pelargonium Extract EPs 7630 in the Treatment of Human Corona Virus-Associated Acute Respiratory Tract Infections - A Secondary Subgroup-Analysis of an Open-Label, Uncontrolled Clinical Trial.
Keck T; Strobl A; Weinhaeusel A; Funk P; Michaelis M
Front Pharmacol; 2021; 12():666546. PubMed ID: 33995094
[No Abstract] [Full Text] [Related]
14. Treatment of signs and symptoms of the common cold using EPs 7630 - results of a meta-analysis.
Schapowal A; Dobos G; Cramer H; Ong KC; Adler M; Zimmermann A; Brandes-Schramm J; Lehmacher W
Heliyon; 2019 Nov; 5(11):e02904. PubMed ID: 31844762
[TBL] [Abstract][Full Text] [Related]
15. Treatment of acute bronchitis with a liquid herbal drug preparation from Pelargonium sidoides (EPs 7630): a randomised, double-blind, placebo-controlled, multicentre study.
Matthys H; Heger M
Curr Med Res Opin; 2007 Feb; 23(2):323-31. PubMed ID: 17288687
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of a fixed combination phytomedicine in the treatment of the common cold (acute viral respiratory tract infection): results of a randomised, double blind, placebo controlled, multicentre study.
Henneicke-von Zepelin H; Hentschel C; Schnitker J; Kohnen R; Köhler G; Wüstenberg P
Curr Med Res Opin; 1999; 15(3):214-27. PubMed ID: 10621929
[TBL] [Abstract][Full Text] [Related]
17. EPs 7630 is effective and safe in children under 6 years with acute respiratory tract infections: clinical studies revisited.
Kamin W; Funk P; Seifert G; Zimmermann A; Lehmacher W
Curr Med Res Opin; 2018 Mar; 34(3):475-485. PubMed ID: 29119837
[TBL] [Abstract][Full Text] [Related]
18. HATRIC: a study of
Whitehead A; Simpson C; Willcox M; Webley F; Hay AD; Butler C; Yao L; Wrixon E; Bell M; Bostock J; Little P; Griffiths G; Moore M
Pilot Feasibility Stud; 2019; 5():98. PubMed ID: 31384480
[TBL] [Abstract][Full Text] [Related]
19. EPs 7630 improves acute bronchitic symptoms and shortens time to remission. Results of a randomised, double-blind, placebo-controlled, multicentre trial.
Matthys H; Funk P
Planta Med; 2008 May; 74(6):686-92. PubMed ID: 18449849
[TBL] [Abstract][Full Text] [Related]
20. Safety of
Kamin W; Behre U; Helm K; Reling B; Funk P; Malek FA
Front Pediatr; 2023; 11():1107984. PubMed ID: 36865690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
